Sulforaphane and Other Nutrigenomic Nrf2 Activators: Can the Clinician's Expectation Be Matched by the Reality?

Oxidative Medicine and Cellular Longevity

Volumn 2016, Issue , 2016, Pages

  Houghton, Christine A ^a   Fassett, Robert G ^a   Coombes, Jeff S ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; CHEMICAL COMPOUNDS; DETOXIFICATION; DIETARY SUPPLEMENTS; FLAVONOIDS; GENES; NUTRITION; PLANTS (BOTANY); TRANSCRIPTION;

CHEMOPREVENTION; CLINICAL EFFICACY; DEFENSE MECHANISM; LOW MOLECULAR WEIGHT; MOLECULAR MECHANISM; NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2; PHYTOCHEMICALS; THERAPEUTIC POTENTIALS;

GENE EXPRESSION;

CURCUMIN; NITRILE; PLANT MEDICINAL PRODUCT; QUERCETIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); RESVERATROL; SILYMARIN; SULFORAPHANE; TAMOXIFEN; THIOGLUCOSIDASE; TRANSCRIPTION FACTOR NRF2; ANTINEOPLASTIC AGENT; GLUCOSINOLATE; GLYCOSIDASE; ISOTHIOCYANIC ACID DERIVATIVE; NFE2L2 PROTEIN, HUMAN; NQO1 PROTEIN, HUMAN; STILBENE DERIVATIVE; SULFORAFAN;

ALTERNATIVE MEDICINE; BIOAVAILABILITY; BRASSICA OLERACEA; BRASSICACEAE; BROCCOLI; CARCINOGENICITY; CELL PROTECTION; CHEMOPROPHYLAXIS; CLINICAL TRIAL (TOPIC); COLON FLORA; DETOXIFICATION; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG EFFICACY; DRUG POTENCY; ENZYME MECHANISM; EXERCISE; GENE EXPRESSION; GENE TARGETING; HUMAN; LIPOPHILICITY; MOLECULAR WEIGHT; NONHUMAN; NUTRIGENOMICS; NUTRITIONAL DEFICIENCY; PHASE 3 CLINICAL TRIAL (TOPIC); PHYTOCHEMISTRY; REVIEW; SIGNAL TRANSDUCTION; SPROUT; STANDARDIZATION; TRANSCRIPTION INITIATION; ANIMAL; AREA UNDER THE CURVE; BRASSICA; CHEMISTRY; DISEASE MODEL; GENE EXPRESSION PROFILING; METABOLISM; NUTRITIONAL SCIENCE; OXIDATION REDUCTION REACTION;

ANIMALS; ANTICARCINOGENIC AGENTS; AREA UNDER CURVE; BRASSICA; CHEMOPREVENTION; CURCUMIN; DISEASE MODELS, ANIMAL; EXERCISE; GENE EXPRESSION PROFILING; GLUCOSINOLATES; GLYCOSIDE HYDROLASES; HUMANS; ISOTHIOCYANATES; NAD(P)H DEHYDROGENASE (QUINONE); NF-E2-RELATED FACTOR 2; NITRILES; NUTRIGENOMICS; NUTRITIONAL SCIENCES; OXIDATION-REDUCTION; PHYTOCHEMICALS; SIGNAL TRANSDUCTION; SILYMARIN; STILBENES;

EID: 84956697082     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2016/7857186     Document Type: Review

References (170)

1. R. L. Swank, "A prospective discussion of past international nutrition catastrophes-indications for the future," Nutrition, vol. 13, no. 4, pp. 344-348, 1997.
2. R. H. Liu, "Health-promoting components of fruits and vegetables in the diet," Advances in Nutrition, vol. 4, no. 3, pp. 384S-392S, 2013.
3. D. James, S. Devaraj, P. Bellur, S. Lakkanna, J. Vicini, and S. Boddupalli, "Novel concepts of broccoli sulforaphanes and disease: induction of phase II antioxidant and detoxification enzymes by enhanced-glucoraphanin broccoli," Nutrition Reviews, vol. 70, no. 11, pp. 654-665, 2012.
4. M. Nicoletti, "Nutraceuticals and botanicals: overview and perspectives," International Journal of Food Sciences and Nutrition, vol. 63, supplement 1, pp. 2-6, 2012.
5. H. -G. Joost, M. J. Gibney, K. D. Cashman et al. , "Personalised nutrition: status and perspectives," British Journal of Nutrition, vol. 98, no. 1, pp. 26-31, 2007.
6. A. M. Ares, M. J. Nozal, and J. Bernal, "Extraction, chemical characterization and biological activity determination of broccoli health promoting compounds," Journal of Chromatography A, vol. 1313, pp. 78-95, 2013.
7. D. E. Stevenson and R. D. Hurst, "Polyphenolic phytochemicals-just antioxidants or much more?" Cellular and Molecular Life Sciences, vol. 64, no. 22, pp. 2900-2916, 2007.
8. H. Sies, "Polyphenols and health: update and perspectives," Archives of Biochemistry and Biophysics, vol. 501, no. 1, pp. 2-5, 2010.
9. C. Manach, G. Williamson, C. Morand, A. Scalbert, and C. Rémésy, "Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies," The American Journal of Clinical Nutrition, vol. 81,no. 1, supplement,pp. 230S-242S, 2005.
10. B. Halliwell, "Are polyphenols antioxidants or pro-oxidants? What do we learn from cell culture and in vivo studies?" Archives of Biochemistry and Biophysics, vol. 476, no. 2, pp. 107-112, 2008.
11. E. J. Calabrese, "Hormesis: why it is important to toxicology and toxicologists," Environmental Toxicology and Chemistry, vol. 27, no. 7, pp. 1451-1474, 2008.
12. B. Pagliaro, C. Santolamazza, F. Simonelli, and S. Rubattu, "Phytochemical compounds and protection from cardiovascular diseases: a state of the art," Bio Med Research International, vol. 2015, Article ID918069, 17 pages, 2015.
13. I. Herr and M. W. Büchler, "Dietary constituents of broccoli and other cruciferous vegetables: implications for prevention and therapy of cancer," Cancer Treatment Reviews, vol. 36, no. 5, pp. 377-383, 2010.
14. T. W. Kensler, P. A. Egner, A. S. Agyeman et al. , "Keap1-Nrf2 signaling: a target for cancer prevention by sulforaphane," Topics in Current Chemistry, vol. 329, pp. 163-178, 2013.
15. D. Boivin, S. Lamy, S. Lord-Dufour et al. , "Antiproliferative and antioxidant activities of common vegetables: a comparative study," Food Chemistry, vol. 112, no. 2, pp. 374-380, 2009.
16. J. V. Higdon, B. Delage, D. E. Williams, and R. H. Dashwood, "Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis," Pharmacological Research, vol. 55, no. 3, pp. 224-236, 2007.
17. X. Zhang, X. -O. Shu, Y. -B. Xiang et al. , "Cruciferous vegetable consumption is associated with a reduced risk of total and cardiovascular disease mortality," American Journal of Clinical Nutrition, vol. 94, no. 1, pp. 240-246, 2011.
18. J. H. Kang, A. Ascherio, and F. Grodstein, "Fruit and vegetable consumption and cognitive decline in aging women," Annals of Neurology, vol. 57, no. 5, pp. 713-720, 2005.
19. Y. Zhang, P. Talalay, C. -G. Cho, and G. H. Posner, "A major inducer of anticarcinogenic protective enzymes from broccoli: Isolation and elucidation of structure," Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 6, pp. 2399-2403, 1992.
20. H. J. Prochaska, A. B. Santamaria, and P. Talalay, "Rapid detection of inducers of enzymes that protect against carcinogens," Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 6, pp. 2394-2398, 1992.
21. K. Singletary and C. MacDonald, "Inhibition of benzo[a]pyrene-and 1,6-dinitropyrene-DNA adduct formation in human mammary epithelial cells bydibenzoylmethane and sulforaphane," Cancer Letters, vol. 155, no. 1, pp. 47-54, 2000.
22. E. L. Cavalieri and E. G. Rogan, "Depurinating estrogen-DNA adducts in the etiology and prevention of breast and other human cancers," Future Oncology, vol. 6, no. 1, pp. 75-91, 2010.
23. D. J. Madureira, F. T. Weiss, P. Van Midwoud, D. E. Helbling, S. J. Sturla, and K. Schirmer, "Systems toxicology approach to understand the kinetics of benzo(a)pyrene uptake, biotransformation, and DNA adduct formation in a liver cell model," Chemical Research in Toxicology, vol. 27, no. 3, pp. 443-453, 2014.
24. P. Moi, K. Chan, I. Asunis, A. Cao, and Y. W. Kan, "Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the -globin locus control region," Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 21, pp. 9926-9930, 1994.
25. J. -M. Lee, J. Li, D. A. Johnson et al. , "Nrf2, a multi-organ protector?" The FASEB Journal, vol. 19, no. 9, pp. 1061-1066, 2005.
26. N. F. Villeneuve, A. Lau, and D. D. Zhang, "Regulation of the Nrf2-keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases," Antioxidants & Redox Signaling, vol. 13, no. 11, pp. 1699-1712, 2010.
27. M. Cuendet, C. P. Oteham, R. C. Moon, and J. M. Pezzuto, "Quinone reductase induction as a biomarker for cancer chemoprevention," Journal of Natural Products, vol. 69, no. 3, pp. 460-463, 2006.
28. A. K. Jaiswal, "Nrf2 signaling in coordinated activation of antioxidant gene expression,"FreeRadical Biologyand Medicine, vol. 36, no. 10, pp. 1199-1207, 2004.
29. J. -M. Lee and J. A. Johnson, "An important role of Nrf2-ARE pathway in the cellular defense mechanism," Journal of Biochemistry and Molecular Biology, vol. 37, no. 2, pp. 139-143, 2004.
30. Y. -J. Surh, J. K. Kundu, and H. -K. Na, "Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals," Planta Medica, vol. 74, no. 13, pp. 1526-1539, 2008.
31. K. N. Lewis, J. Mele, J. D. Hayes, and R. Buffenstein, "Nrf2, a guardian of healthspan and gatekeeper of species longevity," Integrative and Comparative Biology, vol. 50, no. 5, pp. 829-843, 2010.
32. C. Hart, R. Cohen, M. Norwood, and J. Stebbing, "The emerging harmof antioxidants in carcinogenesis," Future Oncology, vol. 8, no. 5, pp. 535-548, 2012.
33. R. Hu, C. Xu, G. Shen et al. , "Gene expression profiles induced by cancer chemopreventive isothiocyanate sulforaphane in the liver of C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice," Cancer Letters, vol. 243, no. 2, pp. 170-192, 2006.
34. M. -K. Kwak, N. Wakabayashi, K. Itoh, H. Motohashi, M. Yamamoto, and T. W. Kensler, "Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway: identification of novel gene clusters for cell survival," The Journal of Biological Chemistry, vol. 278, no. 10, pp. 8135-8145, 2003.
35. A. Rahal, A. Kumar, V. Singh et al. , "Oxidative stress, prooxidants, and antioxidants: the interplay," Bio Med Research International, vol. 2014,Article ID 761264, 19 pages, 2014.
36. L. Valgimigli and R. Iori, "Antioxidant and pro-oxidant capacities of ITCs," Environmental and MolecularMutagenesis, vol. 50, no. 3, pp. 222-237, 2009.
37. J. D. Brooks, V. G. Paton, and G. Vidanes, "Potent induction of phase 2 enzymes in human prostate cells by sulforaphane," Cancer Epidemiology Biomarkers and Prevention, vol. 10, no. 9, pp. 949-954, 2001.
38. S. -D. Cho, G. Li, H. Hu et al. , "Involvement of c-Jun N-terminal kinase in G2/M arrest and caspase-mediated apoptosis induced by sulforaphane in DU145 prostate cancer cells," Nutrition and Cancer, vol. 52, no. 2, pp. 213-224, 2005.
39. A. F. Abdull Razis and N. M. Noor, "Sulforaphane is superior to glucoraphanin in modulating carcinogen-metabolising enzymes in Hep G2 cells," Asian Pacific Journal of Cancer Prevention, vol. 14, no. 7, pp. 4235-4238, 2013.
40. M. G. Botti, M. G. Taylor, and N. P. Botting, "Studies on the mechanism of myrosinase-investigation of the effect of glycosyl acceptors on enzyme activity," Journal of Biological Chemistry, vol. 270, no. 35, pp. 20530-20535, 1995.
41. H. Wu, H. Liang, Q. Yuan, T. Wang, and X. Yan, "Preparation and stability investigation of the inclusion complex of sulforaphane with hydroxypropyl-β-cyclodextrin," Carbohydrate Polymers, vol. 82, no. 3, pp. 613-617, 2010.
42. J. D. Clarke, K. Riedl, D. Bella, S. J. Schwartz, J. F. Stevens, and E. Ho, "Comparison of isothiocyanate metabolite levels and histone deacetylase activity in human subjects consuming broccoli sprouts or broccoli supplement," Journal of Agricultural and Food Chemistry, vol. 59, no. 20, pp. 10955-10963, 2011.
43. G. R. De Nicola, M. Bagatta, E. Pagnotta et al. , "Comparison of bioactive phytochemical content and release of isothiocyanates in selected brassica sprouts," Food Chemistry, vol. 141, no. 1, pp. 297-303, 2013.
44. Y. Jin, M. Wang, R. T. Rosen, and C. -T. Ho, "Thermal degradation of sulforaphane in aqueous solution," Journal of Agricultural and Food Chemistry, vol. 47, no. 8, pp. 3121-3123, 1999.
45. A. T. Dinkova-Kostova, J. W. Fahey, and P. Talalay, "Chemical structures of inducers of nicotinamide quinone oxidoreductase 1 (NQO1),"Methods in Enzymology, vol. 382, pp. 423-448, 2004.
46. M. E. Nimni, B. Han, and F. Cordoba, "Are we getting enough sulfur in our diet?" Nutrition and Metabolism, vol. 4, article 24, 2007.
47. R. F. Grimble and G. K. Grimble, "Immunonutrition: role of sulfur amino acids, related amino acids, and polyamines," Nutrition, vol. 14, no. 7-8, pp. 605-610, 1998.
48. I. F. F. Benzie and S. Wachtel-Galor, "Vegetarian diets and public health: biomarker and redox connections," Antioxidants & Redox Signaling, vol. 13, no. 10, pp. 1575-1591, 2010.
49. J. W. Fahey, Y. Zhang, and P. Talalay, "Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens," Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 19, pp. 10367-10372, 1997.
50. R. H. Dashwood, "Indole-3-carbinol: anticarcinogen or tumor promoter in brassica vegetables?" Chemico-Biological Interactions, vol. 110, no. 1-2, pp. 1-5, 1998.
51. T. W. Kensler, G. -S. Qian, J. -G. Chen, and J. D. Groopman, "Translational strategies for cancer prevention in liver," Nature Reviews Cancer, vol. 3, no. 5, pp. 321-329, 2003.
52. T. M. Buetler, E. P. Gallagher, C. Wang, D. L. Stahl, J. D. Hayes, and D. L. Eaton, "Induction of phase I and phase II drug-metabolizing enzyme mRNA, protein, and activity by BHA, ethoxyquin, and oltipraz," Toxicology and Applied Pharmacology, vol. 135, no. 1, pp. 45-57, 1995.
53. X. Wang, D. J. Tomso, B. N. Chorley et al. , "Identification of polymorphic antioxidant response elements in the human genome," Human Molecular Genetics, vol. 16, no. 10, pp. 1188-1200, 2007.
54. K. Itoh, T. Chiba, S. Takahashi et al. , "An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements," Biochemical and Biophysical Research Communications, vol. 236, no. 2, pp. 313-322, 1997.
55. D. Stewart, E. Killeen, R. Naquin, S. Alam, and J. Alam, "Degradation of transcription factorNrf2 via the ubiquitin-proteasome pathway and stabilization by cadmium," The Journal of Biological Chemistry, vol. 278, no. 4, pp. 2396-2402, 2003.
56. Y. Katoh, K. Iida, M. -I. Kang et al. , "Evolutionary conserved N-terminal domain of Nrf2 is essential for the Keap1-mediated degradation of the protein by proteasome," Archives of Biochemistry and Biophysics, vol. 433, no. 2, pp. 342-350, 2005.
57. A. Kobayashi, M. -I. Kang, H. Okawa et al. , "Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2," Molecular and Cellular Biology, vol. 24, no. 16, pp. 7130-7139, 2004.
58. K. Taguchi, H. Motohashi, and M. Yamamoto, "Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution," Genes to Cells, vol. 16, no. 2, pp. 123-140, 2011.
59. J. A. Hinson, D. W. Roberts, and L. P. James, "Mechanisms of acetaminophen-induced liver necrosis," Handbook of Experimental Pharmacology, vol. 196, pp. 369-405, 2010.
60. I. M. Copple, C. E. Goldring, R. E. Jenkins et al. , "The hepatotoxic metabolite of acetaminophen directly activates the keap1-Nrf2 cell defense system," Hepatology, vol. 48, no. 4, pp. 1292-1301, 2008.
61. G. Chen, Q. Fang, J. Zhang, D. Zhou, and Z. Wang, "Role of the Nrf2-ARE pathway in early brain injury after experimental subarachnoid hemorrhage," Journal of Neuroscience Research, vol. 89, no. 4, pp. 515-523, 2011.
62. N. Juge, R. F. Mithen, and M. Traka, "Molecular basis for chemoprevention by sulforaphane: a comprehensive review," Cellular and Molecular Life Sciences, vol. 64, no. 9, pp. 1105-1127, 2007.
63. D. Liska, M. Lyon, and D. S. Jones, "Detoxification and biotransformational imbalances," Explore: The Journal of Science and Healing, vol. 2, no. 2, pp. 122-140, 2006.
64. N. Laso, S. Mas, M. J. Lafuente et al. , "Induction of NAD(P)H quinone oxidoreductase by vegetables widely consumed in Catalonia, Spain," Nutrition and Cancer, vol. 52, no. 1, pp. 49-58, 2005.
65. P. Talalay, "Chemoprotection against cancer by induction of Phase 2 enzymes," Bio Factors, vol. 12, no. 1-4, pp. 5-11, 2000.
66. X. Gao, A. T. Dinkova-Kostova, and P. Talalay, "Powerful and prolonged protection of human retinal pigment epithelial cells, keratinocytes, and mouse leukemia cells against oxidative damage: the indirect antioxidant effects of sulforaphane," Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 26, pp. 15221-15226, 2001.
67. M. L. Pall and S. Levine, "Nrf2, a master regulator of detoxification and also antioxidant, anti-inflammatory and other cytoprotective mechanisms, is raised by health promoting factors," Sheng Li Xue Bao, vol. 67, no. 1, pp. 1-18, 2015.
68. P. C. Spiess, D. Kasahara,A. Habibovic et al. , "Acroleinexposure suppresses antigen-induced pulmonary inflammation," Respiratory Research, vol. 14, article 107, 2013.
69. A. L. Eggler, K. A. Gay, and A. D. Mesecar, "Molecular mechanisms of natural products in chemoprevention: induction of cytoprotective enzymes by Nrf2,"Molecular Nutrition and Food Research, vol. 52, supplement 1, pp. S84-S94, 2008.
70. R. K. Thimmulappa, K. H. Mai, S. Srisuma, T. W. Kensler, M. Yamamoto, and S. Biswal, "Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray," Cancer Research, vol. 62,no. 18, pp. 5196-5203, 2002.
71. Y. -J. Lee and S. -H. Lee, "Sulforaphane induces antioxidative and antiproliferative responses by generating reactive oxygen species in human bronchial epithelial BEAS-2B cells," Journal of Korean Medical Science, vol. 26, no. 11, pp. 1474-1482, 2011.
72. M. F. Holick, "Vitamin D: evolutionary, physiological and health perspectives," Current Drug Targets, vol. 12, no. 1, pp. 4-18, 2011.
73. M. Schwab, V. Reynders, S. Loitsch, D. Steinhilber, O. Schröder, and J. Stein, "The dietary histone deacetylase inhibitor sulforaphane induces human β-defensin-2 in intestinal epithelial cells," Immunology, vol. 125, no. 2, pp. 241-251, 2008.
74. M. J. Berridge, "Vitamin D cell signalling in health and disease," Biochemical and Biophysical Research Communications, vol. 460, no. 1, pp. 53-71, 2015.
75. X. -L. Chen and C. Kunsch, "Induction of cytoprotective genes through Nrf2/antioxidant response element pathway: a new therapeutic approach for the treatment of inflammatory diseases," Current Pharmaceutical Design, vol. 10, no. 8, pp. 879-891, 2004.
76. J. W. Fahey and P. Talalay, "Antioxidant functions of sulforaphane: a potent inducer of phase II detoxication enzymes," Food and Chemical Toxicology, vol. 37, no. 9-10, pp. 973-979, 1999.
77. A. T. Dinkova-Kostova and P. Talalay, "NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector," Archives of Biochemistry and Biophysics, vol. 501, no. 1, pp. 116-123, 2010.
78. G. P. Sykiotis, I. G. Habeos,A. V. Samuelson, and D. Bohmann, "The role of the antioxidant and longevity-promoting Nrf2 pathway in metabolic regulation," Current Opinion in Clinical Nutrition and Metabolic Care, vol. 14, no. 1, pp. 41-48, 2011.
79. J. H. Suh, S. V. Shenvi, B. M. Dixon et al. , "Decline in transcriptional activity ofNrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid," Proceedings of the NationalAcademy of Sciences of theUnited States ofAmerica, vol. 101, no. 10, pp. 3381-3386, 2004.
80. M. M. Rahman, G. P. Sykiotis, M. Nishimura, R. Bodmer, and D. Bohmann, "Declining signal dependence of Nrf2-MafSregulated gene expression correlates with aging phenotypes," Aging Cell, vol. 12, no. 4, pp. 554-562, 2013.
81. A. T. Dinkova-Kostova and P. Talalay, "Persuasive evidence that quinone reductase type 1 (DT diaphorase) protects cells against the toxicity of electrophiles and reactive forms of oxygen," Free Radical Biology and Medicine, vol. 29,no. 3-4, pp. 231-240, 2000.
82. M. M. Iba and R. J. Caccavale, "Genotoxic bioactivation of constituents of a diesel exhaust particle extract by the human lung," Environmental and Molecular Mutagenesis, vol. 54, no. 3, pp. 158-171, 2013.
83. E. H. Jeffery and K. E. Stewart, "Upregulation of quinone reductase by glucosinolate hydrolysis products from dietary broccoli," Methods in Enzymology, vol. 382, pp. 457-469, 2004.
84. R. P. Robertson, "AIRarg and AIRgluc as predictors of insulin secretory reserve," Transplantation Proceedings, vol. 36, no. 4, pp. 1040-1041, 2004.
85. J. W. Fahey, K. K. Stephenson, A. T. Dinkova-Kostova, P. A. Egner, T. W. Kensler, and P. Talalay, "Chlorophyll, chlorophyllin and related tetrapyrroles are significant inducers ofmammalian phase 2 cytoprotective genes," Carcinogenesis, vol. 26, no. 7, pp. 1247-1255, 2005.
86. T. A. Shapiro, J. W. Fahey, K. L. Wade, K. K. Stephenson, and P. Talalay, "Human metabolism and excretion of cancer chemoprotective glucosinolates and isothiocyanates of cruciferous vegetables," Cancer Epidemiology Biomarkers and Prevention, vol. 7, no. 12, pp. 1091-1100, 1998.
87. J. W. Fahey and T. W. Kensler, "Role of dietary supplements/ nutraceuticals in chemoprevention through induction of cytoprotective enzymes," Chemical Research in Toxicology, vol. 20, no. 4, pp. 572-576, 2007.
88. Y. Yuan, L. Ji, L. Luo et al. , "Quinone reductase (QR) inducers from Andrographis paniculata and identification of molecular target of andrographolide," Fitoterapia, vol. 83, no. 8, pp. 1506-1513, 2012.
89. J. Yang and R. H. Liu, "Induction of phase II enzyme, quinone reductase, in murine hepatoma cells in vitro by grape extracts and selected phytochemicals," Food Chemistry, vol. 114, no. 3, pp. 898-904, 2009.
90. L. Ye, T. Wang, L. Tang et al. , "Poor oral bioavailability of a promising anticancer agent andrographolide is due to extensive metabolism and efflux by P-glycoprotein," Journal of Pharmaceutical Sciences, vol. 100, no. 11, pp. 5007-5017, 2011.
91. C. Gerhäuser, K. Klimo, E. Heiss et al. , "Mechanism-based in vitro screening of potential cancer chemopreventive agents," Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis, vol. 523-524, pp. 163-172, 2003.
92. H. L. Bradlow and M. A. Zeligs, "Diindolylmethane (DIM) spontaneously forms from indole-3-carbinol (I3C) during cell culture experiments," In Vivo, vol. 24, no. 4, pp. 387-391, 2010.
93. E. Cavalieri, D. Chakravarti, J. Guttenplan et al. , "Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention," Biochimica et Biophysica Acta, vol. 1766, no. 1, pp. 63-78, 2006.
94. L. Mulvey, A. Chandrasekaran, K. Liu et al. , "Interplay of genes regulated by estrogen and diindolylmethane in breast cancer cell lines," Molecular Medicine, vol. 13, no. 1-2, pp. 69-78, 2007.
95. H. R. Frydoonfar, D. R. McGrath, and A. D. Spigelman, "The effect of indole-3-carbinol and sulforaphane on a prostate cancer cell line," ANZ Journal of Surgery, vol. 73, no. 3, pp. 154-156, 2003.
96. G. Stoner, B. Casto, S. Ralston, B. Roebuck, C. Pereira, and G. Bailey, "Development of a multi-organ rat model for evaluating chemopreventive agents: efficacy of indole-3-carbinol," Carcinogenesis, vol. 23, no. 2, pp. 265-272, 2002.
97. T. G. Son, S. Camandola, andM. P. Mattson, "Hormetic dietary phytochemicals," NeuroMolecular Medicine, vol. 10, no. 4, pp. 236-246, 2008.
98. M. Zakkar, K. Van der Heiden, L. A. Luong et al. , "Activation of Nrf2 in endothelial cells protects arteries from exhibiting a proinflammatory state," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 11, pp. 1851-1857, 2009.
99. N. Krishnamurthy, Y. Hu, S. Siedlak, Y. Q. Doughman, M. Watanabe, and M. M. Montano, "Induction of quinone reductase by tamoxifen orDPNprotects againstmammary tumorigenesis," The FASEB Journal, vol. 26, no. 10, pp. 3993-4002, 2012.
100. L. L. Stoll, M. L. McCormick, G. M. Denning, and N. L. Weintraub, "Antioxidant effects of statins," Drugs of Today, vol. 40, no. 12, pp. 975-989, 2004.
101. N. -H. Kim, M. -K. Oh, H. J. Park, and I. -S. Kim, "Auranofin, a gold(I)-containing antirheumatic compound, activates Keap1/Nrf2 signaling via Rac1/iNOS signal and mitogenactivated protein kinase activation," Journal of Pharmacological Sciences, vol. 113, no. 3, pp. 246-254, 2010.
102. M. Aburaya, K. -I. Tanaka, T. Hoshino et al. , "Heme oxygenase-1 protects gastric mucosal cells against non-steroidal antiinflammatory drugs,"The Journal of Biological Chemistry, vol. 281, no. 44, pp. 33422-33432, 2006.
103. P. E. Pergola, P. Raskin, R. D. Toto et al. , "Bardoxolone methyl and kidney function in CKD with type 2 diabetes," The New England Journal of Medicine, vol. 365, no. 4, pp. 327-336, 2011.
104. M. B. Sporn, K. T. Liby,M. M. Yore, L. Fu, J. M. Lopchuk, and G. W. Gribble, "New synthetic triterpenoids: potent agents for prevention and treatment of tissue injury caused by inflammatory and oxidative stress," Journal of Natural Products, vol. 74, no. 3, pp. 537-545, 2011.
105. C. Zoja, A. Benigni, and G. Remuzzi, "The Nrf2 pathway in the progression of renal disease," Nephrology Dialysis Transplantation, vol. 29, supplement 1, pp. i19-i24, 2014.
106. J. Liu, "Oleanolic acid and ursolic acid: research perspectives," Journal of Ethnopharmacology, vol. 100, no. 1-2, pp. 92-94, 2005.
107. Q. Q. Wu, Y. Wang, M. Senitko et al. , "Bardoxolone methyl (BARD) ameliorates ischemic AKI and increases expression of protective genes Nrf2, PPARγ, and HO-1," American Journal of Physiology-Renal Physiology, vol. 300, no. 5, pp. 1180-1192, 2011.
108. D. de Zeeuw, T. Akizawa, R. Agarwal et al. , "Rationale and trial design of bardoxolone methyl evaluation in patients with chronic kidney disease and type 2 diabetes: the occurrence of renal events (BEACON)," American Journal of Nephrology, vol. 37, no. 3, pp. 212-222, 2013.
109. A. T. Dinkova-Kostova, K. T. Liby, K. K. Stephenson et al. , "Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress," Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 12, pp. 4584-4589, 2005.
110. M. Ristow, K. Zarse, A. Oberbach et al. , "Antioxidants prevent health-promoting effects of physical exercise in humans," Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 21, pp. 8665-8670, 2009.
111. T. -T. Peternelj and J. S. Coombes, "Antioxidant supplementation during exercise training: beneficial or detrimental?" Sports Medicine, vol. 41, no. 12, pp. 1043-1069, 2011.
112. Q. Zhang, J. Pi, C. G. Woods, and M. E. Andersen, "A systems biology perspective on Nrf2-mediated antioxidant response," Toxicology and Applied Pharmacology, vol. 244, no. 1, pp. 84-97, 2010.
113. V. R. Muthusamy, S. Kannan, K. Sadhaasivam et al. , "Acute exercise stress activates Nrf2/ARE signaling and promotes antioxidant mechanisms in the myocardium," Free Radical Biology and Medicine, vol. 52, no. 2, pp. 366-376, 2012.
114. M. J. M. Magbanua, E. L. Richman, E. V. Sosa et al. , "Physical activity and prostate gene expression in men with low-risk prostate cancer," Cancer Causes and Control, vol. 25, no. 4, pp. 515-523, 2014.
115. L. Wang, X. He, G. D. Szklarz, Y. Bi, Y. Rojanasakul, and Q. Ma, "The aryl hydrocarbon receptor interacts with nuclear factor erythroid 2-related factor 2 to mediate induction of NAD(P)H:quinoneoxidoreductase 1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin," Archives of Biochemistry and Biophysics, vol. 537, no. 1, pp. 31-38, 2013.
116. S. Singh, D. Chakravarti, J. A. Edney et al. , "Relative imbalances in the expression of estrogen-metabolizing enzymes in the breast tissue of women with breast carcinoma," Oncology Reports, vol. 14, no. 4, pp. 1091-1096, 2005.
117. D. Siegel, D. L. Gustafson, D. L. Dehn et al. , "NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger," Molecular Pharmacology, vol. 65, no. 5, pp. 1238-1247, 2004.
118. B. Lajin and A. Alachkar, "The NQO1 polymorphism C609T (Pro187Ser) and cancer susceptibility: a comprehensive metaanalysis," British Journal of Cancer, vol. 109, no. 5, pp. 1325-1337, 2013.
119. S. Rubattu, S. Di Castro,M. Cotugno et al. , "Protective effects of Brassica oleracea sprouts extract toward renal damage in highsalt-fed SHRSP: role of AMPK/PPAR/UCP2 axis," Journal of Hypertension, vol. 33, no. 7, pp. 1465-1479, 2015.
120. H. -J. Cho, J. -E. Kim, D. -D. Kim, and I. -S. Yoon, "In vitroin vivo extrapolation (IVIVE) for predicting human intestinal absorption and first-pass elimination of drugs: principles and applications," Drug Development and Industrial Pharmacy, vol. 40, no. 8, pp. 989-998, 2014.
121. H. Lennernäs, "Modeling gastrointestinal drug absorption requires more in vivo biopharmaceutical data: experience from in vivo dissolution and permeability studies in humans," Current Drug Metabolism, vol. 8, no. 7, pp. 645-657, 2007.
122. M. Hu, "Commentary: bioavailability of flavonoids and polyphenols: call to arms," Molecular Pharmaceutics, vol. 4, no. 6, pp. 803-806, 2007.
123. M. D'Archivio, C. Filesi, R. Var, B. Scazzocchio, and R. Masella, "Bioavailability of the polyphenols: status and controversies," International Journal of Molecular Sciences, vol. 11, no. 4, pp. 1321-1342, 2010.
124. N. Hanlon, N. Coldham, A. Gielbert et al. , "Absolute bioavailability and dose-dependent pharmacokinetic behaviour of dietary doses of the chemopreventive isothiocyanate sulforaphane in rat," British Journal of Nutrition, vol. 99, no. 3, pp. 559-564, 2008.
125. S. K. Nicholson, G. A. Tucker, and J. M. Brameld, "Effects of dietary polyphenols on gene expression in human vascular endothelial cells," Proceedings of the Nutrition Society, vol. 67, no. 1, pp. 42-47, 2008.
126. C. Manach, A. Scalbert, C. Morand, C. Rémésy, and L. Jiménez, "Polyphenols: food sources and bioavailability," American Journal of Clinical Nutrition, vol. 79, no. 5, pp. 727-747, 2004.
127. K. -Y. Yang, L. -C. Lin, T. -Y. Tseng, S. -C. Wang, and T. -H. Tsai, "Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS," Journal of Chromatography B: Analytical Technologies in the Bio Medical and Life Sciences, vol. 853, no. 1-2, pp. 183-189, 2007.
128. T. Walle, "Bioavailability of resveratrol," Annals of the New York Academy of Sciences, vol. 1215, no. 1, pp. 9-15, 2011.
129. S. Javed, K. Kohli, and M. Ali, "Reassessing bioavailability of silymarin," Alternative Medicine Review, vol. 16, no. 3, pp. 239-249, 2011.
130. A. Scalbert, C. Manach,C. Morand, C. Rémésy, and L. Jiménez, "Dietary polyphenols and the prevention of diseases," Critical Reviews in Food Science and Nutrition, vol. 45, no. 4, pp. 287-306, 2005.
131. R. H. Liu, "Potential synergy of phytochemicals in cancer prevention:mechanismof action," Journal of Nutrition, vol. 134, no. 12, supplement, pp. 3479S-3485S, 2004.
132. J. Kanner and T. Lapidot, "The stomach as a bioreactor: dietary lipid peroxidation in the gastric fluid and the effects of plantderived antioxidants," Free Radical Biology and Medicine, vol. 31, no. 11, pp. 1388-1395, 2001.
133. A. J. Vargas and R. Burd, "Hormesis and synergy: pathways and mechanisms of quercetin in cancer prevention and management," Nutrition Reviews, vol. 68, no. 7, pp. 418-428, 2010.
134. G. Galati, S. Teng, M. Y. Moridani, T. S. Chan, and P. J. O'Brien, "Cancer chemoprevention and apoptosis mechanisms induced by dietary polyphenolics," Drug Metabolism and Drug Interactions, vol. 17, no. 1-4, pp. 311-349, 2000.
135. R. Ferraresi, L. Troiano, E. Roat et al. , "Essential requirement of reduced glutathione (GSH) for the anti-oxidant effect of the flavonoid quercetin," Free Radical Research, vol. 39, no. 11, pp. 1249-1258, 2005.
136. M. B. M. van Duursen, J. T. Sanderson, P. C. de Jong, M. Kraaij, and M. van den Berg, "Phytochemicals inhibit catechol-O-methyltransferase activity in cytosolic fractions fromhealthy human mammary tissues: implications for catechol estrogeninduced DNA damage," Toxicological Sciences, vol. 81, no. 2, pp. 316-324, 2004.
137. L. I. Mennen, R. Walker, C. Bennetau-Pelissero, and A. Scalbert, "Risks and safety of polyphenol consumption," The American Journal of Clinical Nutrition, vol. 81, supplement 1, pp. 326S-329S, 2005.
138. A. Shehzad, G. Rehman, and Y. S. Lee, "Curcumin in inflammatory diseases," Bio Factors, vol. 39, no. 1, pp. 69-77, 2013.
139. C. Buhrmann, A. Mobasheri, F. Busch et al. , "Curcumin modulates nuclear factor κB (nf-κB)-mediated inflammation in human tenocytes in vitro: role of the phosphatidylinositol 3-kinase/Akt pathway," Journal of Biological Chemistry, vol. 286, no. 32, pp. 28556-28566, 2011.
140. R. A. Sharma, S. A. Euden, S. L. Platton et al. , "Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance," Clinical Cancer Research, vol. 10, no. 20, pp. 6847-6854, 2004.
141. L. M. Howells, E. P. Moiseeva, C. P. Neal et al. , "Predicting the physiological relevance of in vitro cancer preventive activities of phytochemicals," Acta Pharmacologica Sinica, vol. 28, no. 9, pp. 1274-1304, 2007.
142. B. B. Aggarwal and K. B. Harikumar, "Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases," International Journal of Biochemistry and Cell Biology, vol. 41, no. 1, pp. 40-59, 2009.
143. R. Sareen, N. Jain, and V. Pandit, "Curcumin: a boon to colonic diseases," Current Drug Targets, vol. 14, no. 10, pp. 1210-1218, 2013.
144. S. K. Yadav, A. K. Sah, R. K. Jha, P. Sah, and D. K. Shah, "Turmeric (curcumin) remedies gastroprotective action," Pharmacognosy Reviews, vol. 7, no. 13, pp. 42-46, 2013.
145. G. Garcea, D. J. L. Jones, R. Singh et al. , "Detection of curcumin and itsmetabolites in hepatic tissue and portal blood of patients following oral administration," British Journal of Cancer, vol. 90, no. 5, pp. 1011-1015, 2004.
146. B. Antony, B. Merina, V. S. Iyer, N. Judy, K. Lennertz, and S. Joyal, "A pilot cross-over study to evaluate human oral bioavailability of BCM-95CG (Biocurcumax), a novel bioenhanced preparation of curcumin," Indian Journal of Pharmaceutical Sciences, vol. 70, no. 4, pp. 445-449, 2008.
147. C. D. Lao, M. T. Ruffin IV, D. Normolle et al. , "Dose escalation of a curcuminoid formulation," BMC Complementary and Alternative Medicine, vol. 6, article 10, 2006.
148. J. A. Baur, K. J. Pearson, N. L. Price et al. , "Resveratrol improves health and survival of mice on a high-calorie diet," Nature, vol. 444, no. 7117, pp. 337-342, 2006.
149. K. J. Pearson, J. A. Baur, K. N. Lewis et al. , "Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span," Cell Metabolism, vol. 8, no. 2, pp. 157-168, 2008.
150. E. Morselli, M. C. Maiuri, M. Markaki et al. , "Caloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagy," Cell Death and Disease, vol. 1, no. 1, article e10, 2010.
151. J. M. Smoliga, J. A. Baur, and H. A. Hausenblas, "Resveratrol and health-a comprehensive review of human clinical trials," Molecular Nutrition and Food Research, vol. 55, no. 8, pp. 1129-1141, 2011.
152. B. Agarwal and J. A. Baur, "Resveratrol and life extension," Annals of the New York Academy of Sciences, vol. 1215, no. 1, pp. 138-143, 2011.
153. T. Walle, F. Hsieh,M. H. DeLegge, J. E. Oatis Jr. , and U. K. Walle, "High absorption but very low bioavailability of oral resveratrol in humans,"DrugMetabolismandDisposition, vol. 32,no. 12,pp. 1377-1382, 2004.
154. V. S. Chachay, G. A. Macdonald, J. H. Martin et al. , "Resveratrol does not benefit patients with nonalcoholic fatty liver disease," Clinical Gastroenterology and Hepatology, vol. 12, no. 12, pp. 2092-2103, 2014.
155. O. Vang, N. Ahmad, C. A. Baile et al. , "What is new for an old molecule? systematic review and recommendations on the use of resveratrol," PLoS ONE, vol. 6, no. 6,Article ID e19881, 2011.
156. S. C. Pradhan and C. Girish, "Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine," Indian Journal of Medical Research, vol. 124, no. 5, pp. 491-504, 2006.
157. L. Abenavoli, R. Capasso, N. Milic, and F. Capasso, "Milk thistle in liver diseases: past, present, future," Phytotherapy Research, vol. 24, no. 10, pp. 1423-1432, 2010.
158. B. S. Cornblatt, L. Ye, A. T. Dinkova-Kostova et al. , "Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast," Carcinogenesis, vol. 28, no. 7, pp. 1485-1490, 2007.
159. L. Ye, A. T. Dinkova-Kostova, K. L. Wade, Y. Zhang, T. A. Shapiro, and P. Talalay, "Quantitative determination of dithiocarbamates in human plasma, serum, erythrocytes and urine: pharmacokinetics of broccoli sprout isothiocyanates in humans," Clinica Chimica Acta, vol. 316, no. 1-2, pp. 43-53, 2002.
160. M. A. Riedl, A. Saxon, andD. Diaz-Sanchez, "Oral sulforaphane increases Phase II antioxidant enzymes in the human upper airway," Clinical Immunology, vol. 130, no. 3, pp. 244-251, 2009.
161. J. W. Fahey, S. L. Wehage, W. D. Holtzclaw et al. , "Protection of humans by plant glucosinolates: efficiency of conversion of glucosinolates to isothiocyanates by the gastrointestinal microflora," Cancer Prevention Research, vol. 5, no. 4, pp. 603-611, 2012.
162. Z. Fuller, P. Louis, A. Mihajlovski, V. Rungapamestry, B. Ratcliffe, and A. J. Duncan, "Influence of cabbage processing methods and prebiotic manipulationof colonic microflora on glucosinolate breakdown in man," British Journal of Nutrition, vol. 98, no. 2, pp. 364-372, 2007.
163. T. W. Kensler, J. -G. Chen, P. A. Egner et al. , "Effects of glucosinolate-rich broccoli sprouts on urinary levels of aflatoxin-DNA adducts and phenanthrene tetraols in a randomized clinical trial in He Zuo Township, Qidong, People's Republic of China," Cancer Epidemiology Biomarkers and Prevention, vol. 14, no. 11, part 1, pp. 2605-2613, 2005.
164. N. V. Matusheski, J. A. Juvik, and E. H. Jeffery, "Heating decreases epithiospecifier protein activity and increases sulforaphane formation in broccoli," Phytochemistry, vol. 65, no. 9, pp. 1273-1281, 2004.
165. D. -L. Cheng, K. Hashimoto, and Y. Uda, "In vitro digestion of sinigrin and glucotropaeolin by single strains of Bifidobacterium and identification of the digestive products," Food and Chemical Toxicology, vol. 42, no. 3, pp. 351-357, 2004.
166. C. C. Conaway, S. M. Getahun, L. L. Liebes et al. , "Disposition of glucosinolates and sulforaphane in humans after ingestion of steamed and fresh broccoli," Nutrition and Cancer, vol. 38, no. 2, pp. 168-178, 2000.
167. J. D. Clarke, A. Hsu, K. Riedl et al. , "Bioavailability and interconversion of sulforaphane and erucin in human subjects consuming broccoli sprouts or broccoli supplement in a crossover study design," Pharmacological Research, vol. 64, no. 5, pp. 456-463, 2011.
168. C. A. Houghton, R. G. Fassett, and J. S. Coombes, "Sulforaphane: translational research from laboratory bench to clinic," Nutrition Reviews, vol. 71, no. 11, pp. 709-726, 2013.
169. S. Qin, J. Chen, S. Tanigawa, and D. -X. Hou, "Microarray and pathway analysis highlight Nrf2/ARE-mediated expression profiling by polyphenolic myricetin," Molecular Nutrition and Food Research, vol. 57, no. 3, pp. 435-446, 2013.
170. H. Motohashi, F. Katsuoka, J. D. Engel, and M. Yamamoto, "Small Maf proteins serve as transcriptional cofactors for keratinocyte differentiation in the Keap1-Nrf2 regulatory pathway," Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 17, pp. 6379-6384, 2004.